Ameline, B
Tshilenge, K-T
Weber, M
Biget, M
Libeau, L
Caplette, R
Mendes-Madeira, A
Provost, N
Guihal, C
Picaud, S
Moullier, P
Pichard, V
Cronin, T
Isiegas, C
Article History
Received: 21 February 2017
Revised: 5 July 2017
Accepted: 10 July 2017
First Online: 7 September 2017
Competing interests
: Serge Picaud is a stakeholder in the company Gensight Biologics. All other co-authors declare no conflict of interest.